课题基金 / 基金详情

A Strength Analysis Tool for Studying Healthy Aging via Exercise in C. elegans

A Strength Analysis Tool for Studying Healthy Aging via Exercise in C. elegans
用于研究秀丽隐杆线虫运动健康衰老的强度分析工具
批准号:
9116734
负责人:
MONICA A. DRISCOLL
金额:
$18.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2018-05-31

项目摘要

项目成果

MONICA A. DRISCOLL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Exercise is arguably the most potent approach we can take to defer physical decline associated with aging and to protect against late onset diseases such as diabetes, cancer, and Alzheimer's disease. Molecular understanding of how exercise benefits translate into healthy aging is thus of definitive medical interest. We study fundamental processes relevant to healthy aging in the 959-celled nematode C. elegans. Recently we made a fascinating discovery-C. elegans can exercise (swim) to exhibit training benefits, and appear to gain benefits by molecular pathways conserved in humans. Our initial model development opens up a new research area for understanding how tissue-specific and organism-wide health benefits are induced by exercise, and creates a novel paradigm for identifying exercise mimetic drugs that might promote healthy aging. To really harvest the potential of this model, we need to measure the strength of the tiny C. elegans. We collaborated to develop a strength test in which trained animals thread through a matrix of deformable pillars, and the extent of pillar deflection is used to calculate force. Our "NemaFlex" force detection device is the quantitative foundation with which we expect to break new ground in understanding exercise impact on healthy aging. Here we propose required development to enhance assay throughput and pursue applications that will not only anchor this technology as an essential component of C. elegans exercise evaluation but also accelerate studies on exercise biology and healthy aging in this powerful model. Aim 1 is to develop a novel high throughput tool for direct strength evaluation in C. elegans. This aim will generate an essential tool for analysis of C. elegans strength at multiple life stages, define the exercise regimen that will become the anchor protocol in the field, and reveal features of training in this model. Aim 2 is to use NemaFlex to evaluate exercise mimetic drugs & to facilitate focused pilot genetic screens. This aim will establish critical proof-of-principle for genetic and drug discovery using the NemaFlex. Aim 3 is to initiate dissection of the functional and molecular relationship between exercise and healthy aging, grounded in NemaFlex force measures of training benefits. To begin, we will test how optimized strength training tracks with a broad spectrum of healthspan indicators that decline with age, we will investigate impact of cessation of training on aging quality, and we will ask if exercise mimetic drugs extend healthspan in the absence of training. Our goals will create novel technology that for the first time permits facile quantitativ analysis of exercise adaptations in the powerful C. elegans genetic model. Accomplishment of our tractable aims will anchor a new subfield of genetic investigation of exercise and healthy aging that may influence design of interventions that broadly promote health and defer aging.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/s12915-017-0368-4
发表时间: 2017-04-10
期刊: BMC biology
影响因子: 5.4
作者: [Laranjeiro R, Harinath G, Burke D, Braeckman BP, Driscoll M]
通讯作者: Driscoll M
DOI: 10.1039/c8lc00103k
发表时间: 2018-07-24
期刊: Lab on a chip
影响因子: 6.1
作者: [Rahman M, Hewitt JE, Van-Bussel F, Edwards H, Blawzdziewicz J, Szewczyk NJ, Driscoll M, Vanapalli SA]
通讯作者: Vanapalli SA
Muscle strength deficiency and mitochondrial dysfunction in a muscular dystrophy model of Caenorhabditis elegans and its functional response to drugs.
秀丽隐杆线虫肌营养不良模型中的肌力缺乏和线粒体功能障碍及其对药物的功能反应。
DOI: 10.1242/dmm.036137
发表时间: 2018-12-04
期刊: Disease models & mechanisms
影响因子: 4.3
作者: [Hewitt JE, Pollard AK, Lesanpezeshki L, Deane CS, Gaffney CJ, Etheridge T, Szewczyk NJ, Vanapalli SA]
通讯作者: Vanapalli SA
DOI: 10.1038/s41598-020-73002-6
发表时间: 2020-10-01
期刊: Scientific reports
影响因子: 4.6
作者: [Rahman M, Edwards H, Birze N, Gabrilska R, Rumbaugh KP, Blawzdziewicz J, Szewczyk NJ, Driscoll M, Vanapalli SA]
通讯作者: Vanapalli SA
Molecular and Cell Biological Foundations of Proteostress-Induced Neuronal Extrusion
  • 批准号:
    10753902
  • 项目类别:
  • 资助金额:
    $63.59万
  • 财政年份:
    2023
  • 负责人:
    MONICA A. DRISCOLL
  • 依托单位:
Molecular Underpinnings of Enduring Exercise Benefits
  • 批准号:
    10545757
  • 项目类别:
  • 资助金额:
    $19.63万
  • 财政年份:
    2022
  • 负责人:
    MONICA A. DRISCOLL
  • 依托单位:
Molecular Underpinnings of Enduring Exercise Benefits
  • 批准号:
    10388673
  • 项目类别:
  • 资助金额:
    $23.55万
  • 财政年份:
    2022
  • 负责人:
    MONICA A. DRISCOLL
  • 依托单位:
Defining roles of genetic and age in extracellular elimination of neurotoxic aggregates
  • 批准号:
    10813264
  • 项目类别:
  • 资助金额:
    $15.16万
  • 财政年份:
    2017
  • 负责人:
    MONICA A. DRISCOLL
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: